NMLSF (Restart Life Sciences) Days Payable: 249.65 (As of Mar. 2026) — 99% Below Median


What is Restart Life Sciences Days Payable?

Restart Life Sciences NMLSF +102.41% Days Payable is 249.65 as of Mar. 2026, which is 99% below its 10-year median of 16,749.45. The stock has 3 warning signs investors should review. Among 706 Biotechnology companies, Restart Life Sciences ranks better than 86.12% on this metric.

Restart Life Sciences's average Accounts Payable for the three months ended in Mar. 2026 was $0.15 Mil. Restart Life Sciences's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.05 Mil. Hence, Restart Life Sciences's Days Payable for the three months ended in Mar. 2026 was 249.65.

The historical rank and industry rank for Restart Life Sciences's Days Payable or its related term are showing as below:

NMLSF' s Days Payable Range Over the Past 10 Years
Min: 985   Med: 16749.45   Max: 21170
Current: 985

During the past 13 years, Restart Life Sciences's highest Days Payable was 21170.00. The lowest was 985.00. And the median was 16749.45.

NMLSF's Days Payable is ranked better than
86.12% of 706 companies
in the Biotechnology industry
Industry Median: 113.56 vs NMLSF: 985.00

Restart Life Sciences's Days Payable increased from Mar. 2025 (0.00) to Mar. 2026 (249.65). It may suggest that Restart Life Sciences delayed paying its suppliers.

Restart Life Sciences Days Payable Historical Data

* Premium members only.

The historical data trend for Restart Life Sciences's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Restart Life Sciences Days Payable Chart

Restart Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Restart Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 249.65

NMLSF vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Restart Life Sciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Restart Life Sciences Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Restart Life Sciences's Days Payable distribution charts can be found below:

* The bar in red indicates where Restart Life Sciences's Days Payable falls into.


Restart Life Sciences Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Restart Life Sciences's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0.136 + 0.145) / 2 ) / 0*365
=0.1405 / 0*365
=N/A

Restart Life Sciences's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (0.145 + 0) / 1 ) / 0.053*365 / 4
=0.145 / 0.053*365 / 4
=249.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 249.65 mean?
Restart Life Sciences (NMLSF) has a Days Payable of 249.65 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Restart Life Sciences and its competitors. This is 99% below median its historical median of 16,749.45. Over the past decade, Restart Life Sciences' Days Payable has ranged from 985.00 to 21,170.00. According to the industry distribution chart, Restart Life Sciences ranks #98 out of 706 companies in the Biotechnology industry, placing it in the top 13.9%.
Is Restart Life Sciences' Days Payable too high?
Restart Life Sciences' current Days Payable of 249.65 is 99% below median its 10-year median of 16,749.45. Over the past 10 years, this metric has ranged from a low of 985.00 to a high of 21,170.00. The Biotechnology industry median Days Payable is 113.56. Restart Life Sciences' value of 249.65 is 119.8% above this industry median. Based on the distribution chart, Restart Life Sciences ranks #98 out of 706 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Restart Life Sciences' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Restart Life Sciences ranks #98 out of 706 companies for Days Payable. This places Restart Life Sciences in the top 14% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.56. Restart Life Sciences' value of 249.65 is 119.8% above this benchmark. Historically, Restart Life Sciences' own Days Payable has ranged from 985.00 to 21,170.00 over the past decade. While the company's 10-year median is 16,749.45 vs. the industry median of 113.56, Restart Life Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 706 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Restart Life Sciences's current Days Payable of 249.65 is 119.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Restart Life Sciences and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Restart Life Sciences's current Days Payable is 249.65, which is 99% below median its own 10-year median of 16,749.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Restart Life Sciences stock overvalued right now?
Restart Life Sciences (NMLSF) has a current Days Payable of 249.65. The current Days Payable is 249.65, which is 99% below median its 10-year median of 16,749.45 and 119.8% above the Biotechnology industry median of 113.56. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Restart Life Sciences (NMLSF), the current Days Payable is 249.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Restart Life Sciences Business Description

Other Exchanges HEAL:Canada
Address 700 - 838 West Hastings Street, Vancouver, BC, CAN, V6C 0A6
Restart Life Sciences Corp is a Canadian-based life sciences company dedicated to addressing health challenges with wellness solutions. Its brands include HolyCrap, BrainQ, Brain Balls.